US$ 24.79
ghk-cu clinical trials Buy (50mg) The tri-peptide GHK-Cu complex ameliorates
Description
Dellis AE, Arkoumanis T, Kyprianou C, Papatsoris AG

Notably, liraglutide, a GLP-1 receptor agonist, has been shown to exhibit neuroprotective effects and mitigate cognitive decline in both experimental and observational studies (131)
conditions with HPA axis dysregulation (burnout, chronic stress, PTSD)

Thus, intranasal (IN) drug delivery offers a non-invasive direct, effective in smaller doses, and alternative route to the CNS
